Scientists at Stanford have developed a new PET scan tracer that flags both pancreatic cancer and a lung disease known as idiopathic pulmonary fibrosis.
Jason Melehani, a resident in internal medicine, has had a long and eclectic career path toward developing new therapies to treat tobacco smokers.
Stanford Medicine pulmonologist Mark Nicolls is working with Nobel winner Gregg Semenza to boost the success of lung transplants.
A Stanford biomedical data scientist discusses how computational modeling of big data could help improve personalized chemotherapy selection in the future.
Stanford researchers examined how people react to museum exhibits offering an immersive experience with the single-cell organism Euglena.
A new approach to biobanking that streamlines sample storage and processing is enabling Stanford scientists and doctors to pursue new lines of research.
Through genetic tests and databases of symptoms, doctors in a network of clinical centers help families determine what is affecting their children's health.
A new discovery could provide a way of detecting Parkinson's disease in its earliest stages, before symptoms start. And it could accelerate the development of …
Scientists have used CRISPR-Cas9 screens to reveal more about how the bacteria behind Legionnaire's disease infects humans.
Researchers at Stanford are mining millions of de-identified patient records using machine learning to determine long-term safety of medical devices.
Using neuroimaging and machine learning, researchers were able to predict whether antidepressants would help individual patients.
Entrepreneurs and scientists gathered at Stanford recently to discuss how to use scientific discoveries to launch startups and improve patient care.
Certain brain tumors wire themselves into the brain's electrical communication network, a new Stanford-led study has shown.
Scientists found a sneaky way to stop cold viruses from replicating in mammalian cells by disabling a protein not in the virus but in the cells they infect.
At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.
Stanford scientists have conducted a proof-of-concept experiment in mice that shows they can use blood stem cells to treat a severe brain disease.